Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Neutralization, effector function and immune imprinting of Omicron variants.
Nature. 2023 Sep;621(7979):592-601. doi: 10.1038/s41586-023-06487-6. Epub 2023 Aug 30.
Nature. 2023.
PMID: 37648855
Free PMC article.
Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized mice.
Lempp FA, Volz T, Cameroni E, Benigni F, Zhou J, Rosen LE, Noack J, Zatta F, Kaiser H, Bianchi S, Lombardo G, Jaconi S, Vincenzetti L, Imam H, Soriaga LB, Passini N, Belnap DM, Schulze A, Lütgehetmann M, Telenti A, Cathcart AL, Snell G, Purcell LA, Hebner CM, Urban S, Dandri M, Corti D, Schmid MA.
Lempp FA, et al. Among authors: vincenzetti l.
J Hepatol. 2023 Nov;79(5):1129-1138. doi: 10.1016/j.jhep.2023.07.003. Epub 2023 Jul 17.
J Hepatol. 2023.
PMID: 37459920
Free article.
Item in Clipboard
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants.
Addetia A, Piccoli L, Case JB, Park YJ, Beltramello M, Guarino B, Dang H, Pinto D, Scheaffer S, Sprouse K, Bassi J, Silacci-Fregni C, Muoio F, Dini M, Vincenzetti L, Acosta R, Johnson D, Subramanian S, Saliba C, Giurdanella M, Lombardo G, Leoni G, Culap K, McAlister C, Rajesh A, Dellota E, Zhou J, Farhat N, Bohan D, Noack J, Lempp FA, Cameroni E, Whitener B, Giannini O, Ceschi A, Ferrari P, Franzetti-Pellanda A, Biggiogero M, Garzoni C, Zappi S, Bernasconi L, Kim MJ, Schnell G, Czudnochowski N, Franko N, Logue JK, Yoshiyama C, Stewart C, Chu H, Schmid MA, Purcell LA, Snell G, Lanzavecchia A, Diamond M, Corti D, Veesler D.
Addetia A, et al. Among authors: vincenzetti l.
bioRxiv [Preprint]. 2023 Feb 27:2023.01.17.523798. doi: 10.1101/2023.01.17.523798.
bioRxiv. 2023.
PMID: 36711984
Free PMC article.
Preprint.
Item in Clipboard
An optimized workflow for CRISPR-Cas9 deletion of surface and intracellular factors in primary human T lymphocytes.
Leoni C, Bianchi N, Vincenzetti L, Monticelli S.
Leoni C, et al. Among authors: vincenzetti l.
PLoS One. 2021 Feb 18;16(2):e0247232. doi: 10.1371/journal.pone.0247232. eCollection 2021.
PLoS One. 2021.
PMID: 33600503
Free PMC article.
Item in Clipboard
The contribution of active and passive mechanisms of 5mC and 5hmC removal in human T lymphocytes is differentiation- and activation-dependent.
Vincenzetti L, Leoni C, Chirichella M, Kwee I, Monticelli S.
Vincenzetti L, et al.
Eur J Immunol. 2019 Apr;49(4):611-625. doi: 10.1002/eji.201847967. Epub 2019 Feb 8.
Eur J Immunol. 2019.
PMID: 30698829
Free article.
Item in Clipboard
Epigenetics of T lymphocytes in health and disease.
Leoni C, Vincenzetti L, Emming S, Monticelli S.
Leoni C, et al. Among authors: vincenzetti l.
Swiss Med Wkly. 2015 Oct 23;145:w14191. doi: 10.4414/smw.2015.14191. eCollection 2015.
Swiss Med Wkly. 2015.
PMID: 26496689
Free article.
Review.
Item in Clipboard
Recombinant DNA technology for melanoma immunotherapy: anti-Id DNA vaccines targeting high molecular weight melanoma-associated antigen.
Barucca A, Capitani M, Cesca M, Tomassoni D, Kazmi U, Concetti F, Vincenzetti L, Concetti A, Venanzi FM.
Barucca A, et al. Among authors: vincenzetti l.
Mol Biotechnol. 2014 Nov;56(11):1032-9. doi: 10.1007/s12033-014-9782-9.
Mol Biotechnol. 2014.
PMID: 25027754
Item in Clipboard
Cite
Cite